•  
  •  
 

Abstract

Ambroxol HCl is a mucolytic agent often used to treat respiratory disorders associated with excess mucus secretion. This study aims to determine the beyond-use date (BUD) of ambroxol HCl syrup on the market based on analysis of the decrease in drug content using High-Performance Liquid Chromatography (HPLC) – UV/Vis detector. The HPLC conditions were reversed-phase with a C18 column, mobile phase containing acetonitrile - phosphate buffer 0.05 M pH 4.5 (60:40) at a flow rate of 1.0 ml/min using UV detection at 248 nm. To determine BUD, five syrup preparations (brands) obtained from the Jakarta area were analyzed in triplicate. The retention time for ambroxol HCl was 4.62 minutes. In the validation, ambroxol HCl showed good linearity with r = 0.99985 in the 6 to 36 µg/ml. LOD and LOQ for ambroxol HCl were 0.74 µg/ml and 2.25 µg/ml, respectively. It is also fulfilled the accuracy and precision parameters with a % recovery from 99.04% to 100.94% and CV<2%. This method meets the requirements according to the ICH Q2(R1) guidelines and can be used for the assay of ambroxol HCl syrup. The ambroxol HCl level on all samples was still higher than 90% (until the 36th day). Normality test data result indicated that data must be divided into two groups that are sample A and B, and sample C, D, and E. In conclusion, the extrapolation result showed that the BUD ambroxol HCl syrup was 83 days for sample A and B, and 49 days for sample C, D, and E.

References

Al-Hakkani, M. F. (2019). A Rapid, Developed and Validated RP-HPLC Method for Determination of Azithromycin. SN Applied Sciences, 1(3). https://doi.org/10.1007/s42452-019-0237-6

Bose, Anirbandeep , Acharya, B. R. (2014). HPLC calibration process parameters in terms of system suitability test. Austin Chromatography, 1(2), 1–4.

Cokro, F., Arrang, S. T., Solang, J. A. N., & Sekarsari, P. (2021a). The beyond-use dates perception of drugs in North Jakarta, Indonesia. Indonesian Journal of Clinical Pharmacy, 10(3), 172–179. https://doi.org/10.15416/ijcp.2021.10.3.172

Cokro, F., Arrang, S. T., Solang, J. A. N., & Sekarsari, P. (2021b). The beyond-use dates perception of drugs in North Jakarta, Indonesia. Indonesian Journal of Clinical Pharmacy, 10(3), 172–179. [online] diakses dari https://doi.org/10.15416/ijcp.2021.10.3.172

Gadhvi, M. P., Bhandari, A., Suhagia, B. N., & Desai, U. H. (2013). Development and validation of High Performance Liquid Chromatography method for simultaneous estimation of ambroxol and doxofylline in their combined tablet dosage form. Research Journal of Pharmacy and Technology, 6(2), 200–203. https://doi.org/http://dx.doi.org/10.1155/2013/834240

Gupta, D., Bhatia, D., Dave, V., Sutariya, V., & Gupta, S. V. (2018). Salts of therapeutic agents: Chemical, physicochemical, and biological considerations. Molecules, 23(7), 1–15. https://doi.org/10.3390/molecules23071719

Harmita. (2004). Petunjuk pelaksanaan validasi metode dan cara perhitungannya. Majalah Ilmu Kefarmasian, 1(3), 117–135.

Harmita. (2015). Analisis Fisikokimia : Kromatografi (J. Manurung, Ed.; Volume 2). Jakarta: EGC.

Herawati, F., & Christina, F. (2012). Beyond Use Date (BUD). Rasional, 10(3), 1–6.

ICH Q2. (2022). Validation of Analytical Procedures Q2 (R2). USA: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.

ICH Q2 (R1). (2005). Validation of analytical procedures: Text and methodology Q2 (R1). USA: International council for harmonization of technical requirements for pharmaceuticals for human use.

Jelić, D., Papović, S., Vraneš, M., Gadžurić, S., Berto, S., Alladio, E., Gajić, D., & Janković, B.(2021). Thermo-Analytical and compatibility study with mechanistic explanation of degradation kinetics of ambroxol hydrochloride tablets under non-isothermal conditions. Pharmaceutics, 13(11). https://doi.org/10.3390/pharmaceutics13111910

Kantar, A., Klimek, L., Cazan, D., Sperl, A., Sent, U., & Mesquita, M. (2020). An overview of efficacy and safety of ambroxol for the treatment of acute and chronic respiratory diseases with a special regard to children. Multidisciplinary Respiratory Medicine, 15. https://doi.org/10.4081/mrm.2020.511

Kementerian Kesehatan Republik Indonesia. (2020). Farmakope Indonesia Edisi VI. Jakarta: Kementerian Kesehatan Republik Indonesia.

Ohler, J., Miller, C., & Sheridan, D. (2019). How do expiration and beyond-use dates compare? Nursing, 49(3), 17. https://doi.org/10.1097/01.NURSE.0000553290.72084.04

Oncel, H., Capan, Y., Pinarbasli, O., Bilgin, F., & Sarracoglu, N. (2018). Stabilized pharmaceutical syrup composition comprising terbutaline sulphate and ambroxol hydrochloride. World Intellectual Property Organization.

United States Pharmacopeia. (2019). USP Compounding Standards and Beyond-Use Dates (BUDs). [online] access from https:/www.usp.org/sites/default/files/usp/document/ourwork/compounding/usp-bud-factsheet.pdf.

USP 40. (2017). United State Pharmacopeia (USP) National Formulary 40 NF-35. The United States Pharmacopeial Convention.

Velagaleti, R. (2010). Stability and shelf life of pharmaceutical products. Pharmaceutical Sciences Encyclopedia, 1–24. https://doi.org/10.1002/9780470571224.pse390

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.